Colorectal Cancer Clinical Trial
Official title:
Teaching General Practitioners to Use the Patient-centered Approach When Suggesting Colorectal Cancer Screening
Context : Colorectal cancer (CRC) mass screening has been implemented in France since 2008.
Participation rates remain too low. The objective of this study is to test if the
implementation of a training course focused on communication skills (whether in-person or
e-learning) among general practitioners (GP) would increase the delivery of gFOBT and CRC
screening participation among the target population of each participating GP.
Method : Pragmatic controlled cluster randomized trial with 2 parallel groups: Control versus
Educational Intervention Intervention ; six hour educational training either in person or
through e-learning The Main objective: is to evaluate the effectiveness of an educational
intervention teaching physicians the patient-centered approach, either in-person or through
e-learning, by evaluating their patients' participation in colorectal cancer (CRC) screening
for all risk categories.
Context : Colorectal cancer (CRC) mass screening has been implemented in France since 2008.
Participation rates remain too low. The objective of this study is to test if the
implementation of a training course focused on communication skills (whether in-person or
e-learning) among general practitioners (GP) would increase the delivery of gFOBT and CRC
screening participation among the target population of each participating GP.
Method : Pragmatic controlled cluster randomized trial with 2 parallel groups: Control versus
Educational Intervention .Given that the type of educational intervention modifies the global
organization and medical practices of the participating centers, the randomization will be
done at the level of GP's practice as a cluster unit in order to avoid contamination bias.
Population : All general practitioners practicing in the Île-de-France, Languedoc-Roussillon,
Loire-Atlantique, Midi-Pyrénées, Poitou-Charentes, or Provence-Alpes-Cote-d'Azur regions will
be requested Their patients are eligible if they are 50-74 years old and reside in one of the
above regions.
212 centers are expected with 318 investigating doctors (an average of 1,5 doctors per
center) and 42 358 total patients (21 179 patients in each arm) Intervention ; will be an
educational training either in person or through e-learning GPs from practices in the control
group were asked to continue their usual care, as if they were not participating in this
trial. The whole procedure is the same all over the country i.e. all adults aged 50 to 74 of
each GP's target population receive a letter every two years from the local cancer prevention
association encouraging them to visit their GP and ask for the test. Patients must then send
the test and a completed identity form, contained in an envelope to a central laboratory.
In the intervention group, participating GPs will receive a six-hour training course focusing
on patient-centered care either in person or through e-learning . Two different scenarios for
a video aiming to improve communication with patients were developed: one for a compliant
patient, another for a non-compliant patient based on the four components of the patient
centered clinical method
Objectives :
The Main objective: is to evaluate the effectiveness of an educational intervention teaching
physicians the patient-centered approach, either in-person or through e-learning, by
evaluating their patients' participation in colorectal cancer (CRC) screening for all risk
categories The Secondary objectives are ;
- Assess the effectiveness of this training on moderate-risk patient participation in
organized CRC screening
- Assess the effectiveness of this training on high-risk patient participation in targeted
CRC screening
- Compare the effectiveness of in-person training versus e-learning
- Assess the effect of the training on whether the sequence of tests completed by patients
is appropriate for their risk category (carrying out a test that was given to them,
immediate refusal of the test, carrying out a colonoscopy if the test is positive)
Assess the effectiveness of this training on reducing social inequalities in CRC
screening participation Evaluation criteria : the primary endpoint is patient
participation in the appropriate CRC screening for their level of risk (i.e. completing
the Fecal Occult Blood Test [FOBT] if at moderate risk or a colonoscopy if at high risk)
within 12 months of randomization. The secondary endpoints are: completing the FOBT for
moderate risk patients, completing a colonoscopy for higher risk patients, proportion of
dispensed tests that were completed , proportion of tests refused among those proposed,
proportion of colonoscopies performed among those whose FOBT is positive, patient
screening participation rate according to socio-economic level, proportion of tests that
could not be interpreted
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |